Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Stereochemical properties of quazepam and its affinity for the GABAA receptorTakano, Ryota ; Tanaka, Ryoko ; Nakamura, Kayo ; Tabata, Hidetsugu ; Oshitari, Tetsuta ; Natsugari, Hideaki ; Takahashi, HideyoBioorganic & medicinal chemistry letters, 2024-09, Vol.110, p.129854, Article 129854 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Ophiobolin A derivatives with enhanced activities under tumor-relevant acidic conditionsMaslivetc, Vladimir A. ; Nabiul Hasan, Md ; Boari, Angela ; Zejnelovski, Arben ; Evidente, Antonio ; Sun, Dandan ; Kornienko, AlexanderBioorganic & medicinal chemistry letters, 2024-09, Vol.110, p.129863, Article 129863 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
[1,2,4]Triazolo[1,5-a]pyrimidine derivatives: Structure-activity relationship study leading to highly selective ENPP1 inhibitorsKawaguchi, Mitsuyasu ; Minami, Shohei ; Ieda, Naoya ; Nakagawa, HidehikoBioorganic & medicinal chemistry letters, 2024-09, Vol.110, p.129820, Article 129820 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Extended voltage imaging in cardiomyocytes with a triplet state quencher-stabilized silicon rhodamineMartinez, Kayli N. ; Gerstner, Nels C. ; Yang, Samantha J. ; Miller, Evan W.Bioorganic & medicinal chemistry letters, 2024-09, Vol.109 (C), p.129842, Article 129842 [Periódico revisado por pares]United Kingdom: Elsevier LtdTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
PEG-lipid-modified agonistic antibody against tumor necrosis factor receptor family elicits superior apoptosis-inducing activity against human carcinomaNiwa, Takako ; Kasuya, Yuji ; Ichikawa, Kimihisa ; Yoshida, Hiroko ; Kurimoto, Akiko ; Tanaka, Kento ; Morita, KojiBioorganic & medicinal chemistry letters, 2024-09, Vol.109, p.129840, Article 129840 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Michael addition-activated alkylation of G-quadruplex DNA with methylamine-protected vinyl-quinazolinone derivativesChen, Yutong ; Onizuka, Kazumitsu ; Nagatsugi, FumiBioorganic & medicinal chemistry letters, 2024-09, Vol.109, p.129855, Article 129855 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Key challenges in TB drug discovery: A perspectiveShaik, Baji Baba ; Karpoormath, RajshekharBioorganic & medicinal chemistry letters, 2024-09, Vol.109, p.129846, Article 129846 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Detecting 2′-5′-adenosine linked nucleic acids via acylation of secondary hydroxy functionalityChen, Xiaoqian ; Guo, Yuyang ; Wang, RuiBioorganic & medicinal chemistry letters, 2024-09, Vol.109, p.129847, Article 129847 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Novel 4-[4-(4-methylpiperazin-1-yl)phenyl]-6-arylpyrimidine derivatives and their antitrypanosomal activities against T.bruceiTaylor, Annie E. ; Hering, Moritz ; Elsegood, Mark R.J. ; Teat, Simon J. ; Weaver, George W. ; Arroo, Randolph R.J. ; Kaiser, Marcel ; Maeser, Pascal ; Bhambra, Avninder S.Bioorganic & medicinal chemistry letters, 2024-09, Vol.109 (C), p.129825, Article 129825 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
Design and synthesis of novel fluorene derivatives as inhibitors of pyruvate dehydrogenase kinaseInoue, Masafumi ; Nagamori, Hironobu ; Morita, Toru ; Kobayashi, Satoru ; Suzawa, Koichi ; Kitao, Yuki ; Saito, Tomoyuki ; Kawahara, Iichiro ; Orita, Takuya ; Akai, Shota ; Adachi, Tsuyoshi ; Motomura, TakahisaBioorganic & medicinal chemistry letters, 2024-09, Vol.109, p.129839, Article 129839 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |